Page last updated: 2024-08-23

carbimazole and 3,3',5-triiodothyroacetic acid

carbimazole has been researched along with 3,3',5-triiodothyroacetic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Baldet, L; Boegner, C; Bringer, J; Daurès, JP; Galtier-Dereure, F; Grabar, S; Jaffiol, C; Osman, A; Pujol, P; Raye, R1

Trials

1 trial(s) available for carbimazole and 3,3',5-triiodothyroacetic acid

ArticleYear
TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates.
    Clinical endocrinology, 1998, Volume: 48, Issue:5

    Topics: Adolescent; Adult; Antithyroid Agents; Carbimazole; Depression, Chemical; Drug Therapy, Combination; Female; Follow-Up Studies; Graves Disease; Humans; Male; Prospective Studies; Thyrotropin; Triiodothyronine

1998

Other Studies

1 other study(ies) available for carbimazole and 3,3',5-triiodothyroacetic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010